5.76BMarket Cap
47.25P/E TTM
Amneal Pharmaceuticals Inc
Key Figures
18.170Open
18.430High
2.01MVolume
47.25P/E TTM
13.97P/E Dynamic
--Dividend TTM
0.64%Turnover Ratio
18.500Prev. Close
17.920Low
27.47MTurnover
LossP/E Static
-81.40P/B
0.00%Div Yield TTM
5.25%ROA
15.42052wk High
1.07Volume Ratio
-116.89MNet Profit
314.56MShares
0.3877EPS TTM
1.31Beta
-155.38%ROE
7.07052wk Low
2.76%Amplitude
42.01%Gross Margin
5.76BMarket Cap
4.83Reward/Risk
1.93%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Amneal Pharmaceuticals Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 37 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 18.84.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Amneal Pharmaceuticals Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Amneal Pharmaceuticals Inc Highlights
StrengthsRisks
Amneal Pharmaceuticals Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Amneal Pharmaceuticals Inc
AMRX
5
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Amneal Pharmaceuticals Inc Info
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Ticker SymbolAMRX
CompanyAmneal Pharmaceuticals Inc
CEOPatel (Chintu)
Websitehttps://amneal.com/
Shareholders
FAQs
What is the current price of Amneal Pharmaceuticals Inc (AMRX)?
The current price of Amneal Pharmaceuticals Inc (AMRX) is 18.32.
What is the symbol of Amneal Pharmaceuticals Inc?
The ticker symbol of Amneal Pharmaceuticals Inc is AMRX.
What is the 52-week high of Amneal Pharmaceuticals Inc?
The 52-week high of Amneal Pharmaceuticals Inc is 15.42.
What is the 52-week low of Amneal Pharmaceuticals Inc?
The 52-week low of Amneal Pharmaceuticals Inc is 7.07.
What is the market capitalization of Amneal Pharmaceuticals Inc?
The market capitalization of Amneal Pharmaceuticals Inc is 5.76B.
Is Amneal Pharmaceuticals Inc (AMRX) currently rated as Buy, Hold, or Sell?
According to analysts, Amneal Pharmaceuticals Inc (AMRX) has an overall rating of Buy, with a price target of 18.84.
What is the Earnings Per Share (EPS TTM) of Amneal Pharmaceuticals Inc (AMRX)?
The Earnings Per Share (EPS TTM) of Amneal Pharmaceuticals Inc (AMRX) is 0.23.